retatrutide release date 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide UK 2026: Phase 3

PMID: 2778217

in: PubMed | Google Scholar 1 Department of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA

Neuronal gutbrain connection Gutbrain signaling is a bidirectional avenue of communication

Perimenopause, postpartum sleep, and inflammation Three questions from paid subscribers this week, all from women on a GLP-1

In the SURPASS-3 trial, tirzepatide showed an 8.1% reduction in MRI-measured liver fat and AST, ALT and gamma-glutamyltransferase vs

The specificity and efficiency of TR knockout was confirmed, as evident from the significantly decreased mRNA levels of Thrb in the liver but not in the adipose tissues, muscle, heart, and ileum of LTRKO mice (Supplementary Fig